Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.58 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.52 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.50 |
| ▸ | PAOX | Q6QHF9 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14507335 | 0.93 | KDM4E (0.62) | TSHRKDM4EMAPK1HIF1AADRA1A | |
| SCHEMBL130413 | 0.91 | KDM4E (0.67) | TSHRKDM4EMAPK1HIF1AADRA1A | |
| SCHEMBL15146914 | 0.86 | TSHR (0.50) | TSHRKDM4EMAPK1HIF1AADRA1A | |
| SCHEMBL3407201 | 0.86 | TSHR (0.57) | TSHRKDM4EMAPK1HIF1AADRA1A | |
| SCHEMBL14073945 | 0.85 | KDM4E (0.57) | TSHRKDM4EMAPK1HIF1AADRA1A | |
| SCHEMBL860790 | 0.84 | KDM4E (0.56) | TSHRKDM4EMAPK1HIF1AADRA1A | |
| SCHEMBL21538522 | 0.82 | TSHR (0.61) | TSHREPHX2ALDH1A1SMN1; SMN2LMNA | |
| SCHEMBL50331 | 0.81 | CYP1A2 (0.53) | KDM4EMAPK1HIF1AADRA1AEPHX2 | |
| SCHEMBL861294 | 0.81 | KDM4E (0.52) | TSHRKDM4EMAPK1HIF1AADRA1A | |
| SCHEMBL7670643 | 0.80 | TSHR (0.58) | TSHREPHX2ALDH1A1SMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006119283-A2 | ANTI-ODOR COMPOSITIONS AND THERAPEUTIC USE | YU RUEY J (US) | 2006-11-09 | — | — | WO | claimed |
| US-20060251597-A1 | ANTI-ODOR COMPOSITIONS AND THERAPEUTIC USE | YU RUEY J | 2006-11-09 | — | — | US | claimed |
| US-12138238-B2 | Compositions comprising N-Acetyl Methyl GABA and related methods | MBI Distributing (US) | 2024-11-12 | — | — | US | disclosed |
| US-12138237-B2 | Compositions comprising N-Acetyl Methyl GABA and related methods | MBI Distributing (US) | 2024-11-12 | — | — | US | disclosed |
| US-12138236-B2 | Compositions comprising N-Acetyl Methyl GABA and related methods | MBI Distributing (US) | 2024-11-12 | — | — | US | disclosed |
| CN-114085179-B | Preparation method of N-acetyl-5-methoxy tryptamine | 福建科宏生物工程股份有限公司 | 2024-05-03 | — | — | CN | disclosed |
| US-11957653-B2 | Compositions comprising N-acetyl methyl GABA and related methods | MBI Distributing (US) | 2024-04-16 | — | — | US | disclosed |
| US-20240041815-A1 | COMPOSITIONS COMPRISING N-ACETYL METHYL GABA AND RELATED METHODS | MBI Distributing (US) | 2024-02-08 | — | — | US | disclosed |
| US-20240024272-A1 | COMPOSITIONS COMPRISING N-ACETYL METHYL GABA AND RELATED METHODS | MBI Distributing (US) | 2024-01-25 | — | — | US | disclosed |
| US-20230364048-A1 | COMPOSITIONS COMPRISING N-ACETYL METHYL GABA AND RELATED METHODS | MBI Distributing (US) | 2023-11-16 | — | — | US | disclosed |
| WO-2022087317-A1 | THIOHYDROXYPYRIDINE CHELATES | LUMIPHORE, INC. (US) | 2022-04-28 | — | — | WO | disclosed |
| WO-2006119283-A2 | ANTI-ODOR COMPOSITIONS AND THERAPEUTIC USE | YU RUEY J (US) | 2006-11-09 | — | — | WO | disclosed |
| CN-1597114-A | Chiral organic, inorganic polymer assembled catalyst, synthesis method and use | SHANGHAI INST ORGANIC CHEM (CN) | 2005-03-23 | — | — | CN | disclosed |
| US-6355640-B1 | TREATMENT OF HYPERTENSION, UROGENITAL DISORDERS AND FORMED BY WITTIG REACTION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-03-12 | — | — | US | disclosed |
| US-5773530-A | USEFUL AS PSYCHOSTIMULANTS, ANTIHYPERTENSIVE AGENTS AND REMEDIES FOR RENAL FAILURE, DIURETICS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-06-30 | — | — | US | disclosed |
| EP-0737193-A1 | PYRAZOLOPYRIDINE ADENOSINE ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-10-16 | — | — | EP | disclosed |
| WO-1995018128-A1 | PYRAZOLOPYRIDINE ADENOSINE ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-07-06 | — | — | WO | disclosed |
| EP-0035228-B1 | TETRAZOLE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF, AND ANTI-ULCER COMPOSITION CONTAINING THE SAME | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1985-01-02 | — | — | EP | disclosed |
| US-4372953-A | Tetrazole derivatives, and anti-ulcer composition containing the same | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1983-02-08 | — | — | US | disclosed |
| EP-0035228-A1 | Tetrazole derivatives, process for the preparation thereof, and anti-ulcer composition containing the same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1981-09-09 | — | — | EP | disclosed |